ReCode Therapeutics to Participate in February Conferences

MENLO PARK, Calif.--(BUSINESS WIRE)--ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA and gene correction therapeutics, today announced that company management will participate in the upcoming February conferences: William Blair Private Company Focus Conference Format: Fireside Chat Date: February 22, 2024 Time: 12:00 p.m. ET Location: Virtual Evercore ISI 2024 Emerging Biotech Conference Format: Company Presentation D